Salumedia Labs

What Salumedia Labs does

Adhera Health, which acquired Salumedia Labs in 2021 and now operates from dual headquarters in Santa Cruz, California and Spain, is a privately held digital health company focused on families managing pediatric chronic conditions. Its core technology is the Adhera AI Health Agentic Platform, built on proprietary Small Language Models (SLMs) trained on whole-family datasets and an AI-driven health recommender system that delivers empathic, condition-specific AI Health Agents (Family Caregiver Coping, Wraparound Services, Family Insights, Clinician Liaison, and Navigator agents). The platform ingests data from wearables (Garmin, Apple Health, Fitbit, Google Fit, Oura, Withings) and medical devices (CGMs such as Freestyle Libre, insulin pumps, BMI trackers) and powers the Adhera Caring Digital Program (ACDP), the Adhera Precision Digital Companion, and condition-specific modules including the Adhera Rheumatology Digital Program and Adhera Fatigue Digital Program. Clinical evidence includes a documented 75% adherence improvement in pediatric growth hormone disorders, published in JMIR Pediatrics & Parenting and presented at ENDO, ADA, ISPAD, AMIA, and ACR conferences.

The company sells subscription-based access to healthcare providers, employers offering caregiver benefits, commercial payors, and Medicaid managed care organizations through enterprise field sales, with families entering via pilot programs, clinical partnerships, employer benefits, payor-sponsored offerings, or beta testing. Pricing is not publicly disclosed. The buyer base is intentionally diversified across providers, employers, payors, and public programs (including CalAIM-aligned wraparound care), though disclosed named relationships to date skew toward clinical research partners and pharma study sponsors (Hospital Universitario Miguel Servet, Children's Hospital Los Angeles, Merck KGaA, Novo Nordisk, Institut Català de la Salut, Universidad Veracruzana, AbbVie, University of Minnesota, Spanish Society of Rheumatology).

Founded around 2015 and led by CEO Ricardo C. Berrios and Chief Scientific Officer Luis Fernandez-Luque, PhD, the company has historically been funded by non-dilutive grants, including a €459,682 CDTI/ERDF grant for the 2020-2022 COVIDAI project and a 2023 NIH/NIMHD award to adapt the platform for the U.S. Latinx population. The platform is HIPAA, GDPR, CCPA (with 2025 updates), and HITRUST CSF-aligned, and integrates with value-based care, care-management, telehealth, and reimbursement frameworks. Headcount is reported at 1-10 employees, and no equity funding rounds or revenue figures are disclosed.

Name

Salumedia Labs

Legal name

Adhera Health Inc.

Website

https://adherahealth.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

Adhera Health, which acquired Salumedia Labs in 2021, is an AI-native digital health company building Small Language Model-powered, family-centered platforms that deliver empathic support for pediatric chronic conditions, sold via enterprise subscriptions to providers, payors, and employers.

Ownership category

akta.pro rank

Product category

Pediatric Digital Health Platform

NAICS

Individual and Family Services (6241), Services for the Elderly and Persons with Disabilities (624120)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Prepackaged Software (7372)

akta.pro primary industry

Therapeutic Companion Apps (Drug-Device-Digital Combination) (HLACANAH)

akta.pro secondary industry

EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps (HLACAAAN)

Keywords

• Pediatric digital health
• AI health platform
• Chronic care management
• Caregiver support software
• Family health technology

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Adhera AI Health Agentic Platform Subscription: The platform integrates seamlessly with value-based care, care-management, telehealth, and reimbursement frameworks across providers, payors, and employers enabling scalable whole-family support. Families can access ACDP through pilot programs, clinical partnerships, employer benefits, or payor-sponsored offerings.
2. Adhera Caring Digital Program (ACDP): Clinically grounded, AI-enabled mobile program delivered via subscription. Includes digital health coaching, personalized education, emotional and behavioral guidance, and access to a health coach.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Salumedia Labs (operating as Adhera Health since 2021 acquisition) provides an AI-powered digital health platform delivering empathic, personalized support to families managing pediatric chronic conditions. The core offering includes the Adhera AI Health Agentic Platform with condition-specific Small Language Models powering AI health agents, and the Adhera Precision Digital Companion that delivers adaptive self-management programs via mobile app. The platform integrates with wearables, CGMs, and insulin pumps, and is sold via subscription to healthcare providers, employers, payors, and directly to families through beta programs and clinical partnerships.

Product overview

Adhera Health is an AI-native digital health company providing an integrated platform of AI-powered products for family-centered pediatric chronic care. The core offering consists of the Adhera AI Health Agentic Platform (built on proprietary Small Language Models) and the Adhera Precision Digital Companion Platform, which powers the Adhera Caring Digital Program (ACDP) — a clinically grounded, AI-enabled mobile program. The AI Health Agents (including Family Coping Agent, Wraparound Services Agent, Family Insights Agent, Clinician Liaison Agent, and Navigator Agent) operate within this platform ecosystem to deliver empathic, emotionally intelligent support. The Adhera Rheumatology Digital Program and Adhera Fatigue Digital Program are condition-specific modules built on the same platform architecture. The platform integrates with wearables (Garmin, Apple Health, Fitbit, Google Fit, Oura, Withings) and medical devices (CGMs, insulin pumps, BMI trackers) and connects with electronic Patient Reported Outcomes systems.

Differentiator

Problem solved

Functional benefit

Brands

• Adhera Caring Digital Program (ACDP): Clinically grounded, AI-enabled mobile program designed to improve daily care support and quality of life for families managing pediatric chronic conditions.
• Adhera AI Health Agentic Platform
• Adhera Precision Digital Companion
• Adhera Rheumatology Digital Program
• Adhera Fatigue Digital Program

Products and services

• Adhera AI Health Agentic Platform Whole-family AI health agent platform extending clinical care into the home with continuous, empathic, emotionally intelligent support for families managing pediatric chronic conditions. Built on proprietary, whole-family training datasets with condition-specific Small Language Models.
• Adhera Precision Digital Companion Adaptive self-management platform delivering highly personalized programs using an AI-driven recommender system to address mental and physical fatigue in people with chronic conditions and their family caregivers. Combines wearable sensors, ePROs, and AI-based health recommendations.
• Adhera Caring Digital Program (ACDP) Clinically grounded, AI-enabled mobile program providing daily care support and quality of life improvement for families managing pediatric chronic conditions. Delivers evidence-based digital support, personalized education, emotional and behavioral guidance, and access to a health coach.
• Adhera Rheumatology Digital Program Digital health program supporting rheumatic and musculoskeletal patients with adaptive self-management and electronic Patient Reported Outcomes (ePROs) monitoring. Built using the Adhera Precision Digital Companion Platform.
• Adhera Fatigue Digital Program Digital program focused on addressing fatigue management for chronic conditions and their family caregivers, part of the adaptive self-management platform.

Quantifiable outcome

• 75% improvement in adherence for pediatric growth hormone disorders
• +4 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability6 records

Feature4 records

Partnerships

Nine partnerships are on record, tiered regional, core and minor.

• Spanish Healthcare Organizations AllianceregionalStrategic or Co-development Partner · 19 December 2023Alliance to adapt digital interventions for childhood obesity with key Spanish healthcare organizations.
• Universidad VeracruzanaregionalStrategic or Co-development Partner · 15 June 2023Clinical study partnership to validate Adhera Fatigue Digital Program for Type 2 Diabetes self-management and glycemic control.
• Hospital Universitario Miguel Servet (SALUD)coreStrategic or Co-development PartnerClinical partner for pediatric growth hormone disorders and Type 1 Diabetes studies. Led CARING-T1D study demonstrating 75% adherence improvement and reduced caregiver anxiety. Principal investigator Dr. Antonio de Arriba.
• Novo NordiskcoreStrategic or Co-development PartnerSponsor of CARING-T1D study examining digital companion impact on caregivers of children with Type 1 Diabetes. Demonstrated positive effect on parent wellbeing and integrated care via advanced AI algorithms.
• Merck KGaAcoreStrategic or Co-development PartnerClinical partner for pediatric growth hormone disorders research. Study showed improved adherence (75%), reduced stress, and increased motivation.
• Children's Hospital Los Angeles (CHLA)coreStrategic or Co-development PartnerPartner in NIH/NIMHD-funded research on overcoming stigma in Latino pediatric care for childhood obesity. Dr. Jennifer Raymond leading clinical research on pediatric diabetes including physical and mental wellbeing of family caregivers of Latinx children with T1D.
• Institut Català de la Salut (ICS) / Government of SpainregionalStrategic or Co-development PartnerClinical partner for childhood obesity study in Spain. Research showed increased family engagement, healthy habits, and weight reduction.
• University of MinnesotaregionalStrategic or Co-development PartnerResearch partner in pediatric digital health alongside Children's Hospital Los Angeles and global partners.
• Spanish Society of RheumatologyminorStrategic or Co-development PartnerClinical partner for rheumatoid arthritis study support alongside AbbVie.

Scale indicators7 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Glooko: Glooko is a unified diabetes data management platform that integrates with CGMs, insulin pumps, and blood glucose meters. It is a direct peer to Adhera in providing AI-driven diabetes management with device integration for providers and patients.
• DarioHealth: DarioHealth is a digital therapeutics company providing AI-driven, data-validated chronic condition management for diabetes, hypertension, musculoskeletal, and mental health. It is a direct peer to Adhera in multi-condition digital therapeutics sold to employers and payors.
• mySugr (Roche): mySugr, part of Roche, is a leading diabetes management app that integrates with CGMs and insulin pumps. It is a direct peer to Adhera in providing mobile-based diabetes self-management with CGM and insulin pump integrations, though it serves both adults and pediatric patients.
• Akili Interactive: Akili Interactive is a prescription digital therapeutics company focused on cognitive dysfunction, including pediatric ADHD. It is a direct peer to Adhera in pediatric-focused digital therapeutics with FDA-cleared software products and a similar enterprise go-to-market motion.
• WellDoc: WellDoc develops FDA-cleared digital therapeutics for diabetes and other chronic conditions via its BlueStar platform. It is a direct peer to Adhera in the prescription digital therapeutics space for diabetes management and chronic disease self-management.
• Better Therapeutics: Better Therapeutics is a prescription digital therapeutics company developing FDA-cleared, app-based therapies for cardiometabolic conditions. It is a direct peer to Adhera in regulated digital therapeutics for chronic disease management with similar reimbursement pathways.
• Virta Health: Virta Health is a digital therapeutics company focused on type 2 diabetes reversal and metabolic health. It is a direct peer to Adhera in selling AI- and coaching-driven programs to employers, payors, and health systems for chronic condition management.
• Omada Health: Omada Health is a digital therapeutics company focused on chronic disease management (diabetes, prediabetes, hypertension, musculoskeletal conditions). It is a direct peer to Adhera in selling digital health solutions to employers, payors, and providers for chronic condition self-management and adherence.
• Cognoa: Cognoa is a pediatric behavioral health AI company that has developed FDA-authorized diagnostic and therapeutic digital health solutions for autism and other pediatric conditions. It is a direct peer to Adhera in pediatric AI-driven digital health with similar regulatory milestones.

Broad incumbents

• Livongo (Teladoc Health): Livongo, now part of Teladoc Health, pioneered AI-driven diabetes and chronic condition management with coaching, connected devices, and behavioral nudges. It directly competes with Adhera in diabetes digital therapeutics, though it has a broader adult-focused offering and greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/adhera-health-inc

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds5 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Salumedia Labs